"Clinical study protocols may involve more than one PET [amyloid-beta] scan per patient,” the CMS announcement said.

PET/CT imaging in these patients increases overall survival depending on the cancer’s stage, with those diagnosed with stage 3A and 3B NSCLC appearing to benefit the most from the exam. 

This week in AJR, experts shared how they were able to reduce FDG PET scan acquisition times by 33%, thus reducing the amount of total radiation exposure to more vulnerable pediatric patients. 

The study touts the benefits of targeted radionuclide alpha therapy for patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who have not had success with other treatments.

Salvage radiation therapy guidelines for patients with prostate cancer recurrence need to be updated to include findings identified on PSMA PET, according to new research shared at SNMMI’s annual conference this week. 

Siemens Healthineers splashed an FDA-approved SPECT/CT system June 12 at the 2022 annual meeting of the Society of Nuclear Medicine & Nuclear Imaging in Vancouver, B.C.

“High-quality artificial intelligence-generated images preserve vital information from raw PET images without the additional radiation exposure from CT scans,” experts involved in the study explained.

The company’s CEO, Greg Piefer, detailed the plans at the Wisconsin Entrepreneurs’ Conference on June 2, stating that production would be achieved via small-scale nuclear transmutation.